To quantify differences in frequency of putative cancer stem cell populations in both cell lines, we used flow cytometry to assess the enzymatic activity of aldehyde dehydrogenases (ALDH) and the expression level of the cell surface markers CD44 and CD24. This evidence concerns the gene CD44 and cancer.